CI

At a glance

ClinicalIndex Comparison Record
Phase 3Unknown· 225 enrolled
Drug / intervention
Conventional Fractionated Intensity Modulated Radiotherapy +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00667888
NCT00667888Phase 3Unknown
CompareCT.gov

A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation

M.D. Anderson Cancer Center·interventional·Posted Apr 28, 2008·Updated Jan 25, 2021

In Brief

A Phase 3 clinical trial evaluating Conventional Fractionated Intensity Modulated Radiotherapy and Hypofractionated Intensity Modulated Radiotherapy for Prostate Cancer. Targeting 225 participants across 1 site.

Detailed Summary

The goal of this clinical research study is to compare using external beam radiotherapy with intensity modulated beams for fewer days at a higher dose per day to the same type of therapy for more days at a lower dose per day in the treatment of prostate cancer. The safety of these treatments will also be studied and compared.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 3UnknownOverdue
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 28, 2008
Enrollment StartJan 3, 2001
Primary CompletionOct 12, 2015
Study CompletionOct 1, 2021
TodayJul 2, 2026
Enrollment to primary: 14.8 yearsPosted 18.2 years ago

Interventions

Conventional Fractionated Intensity Modulated Radiotherapyradiation

A total dose of 75.6 Gy will be delivered in 42 fractions to the planning target volume (PTV).

Hypofractionated Intensity Modulated Radiotherapyradiation

A total dose of 72 Gy will be delivered in 30 fractions to the PTV.